Christopher Anzalone is President and Chief Executive Officer of Arrowhead Pharmaceuticals, Inc. (ARWR). The company reported total compensation of $9,029,861 for fiscal year 2025.
| Salary | $981,046 |
|---|---|
| Bonus | $0 |
| Stock awards | $6,810,292 |
| Option awards | $0 |
| Non-equity incentive plan | $1,236,000 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $2,523 |
| Total | $9,029,861 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Arrowhead Pharmaceuticals, Inc. filed January 27, 2026, accession 0000879407-26-000019.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | President and Chief Executive Officer | $981,046 | $0 | $6,810,292 | $0 | $1,236,000 | $0 | $2,523 | $9,029,861 |
| FY2024 | President and Chief Executive Officer | $951,012 | $0 | $10,319,000 | $0 | $1,152,000 | $0 | $1,461 | $12,423,473 |
| FY2023 | President and Chief Executive Officer | $902,522 | $0 | $8,314,056 | $0 | $700,000 | $0 | $1,515 | $9,918,093 |
Totals as disclosed in each year's own compensation disclosure for Arrowhead Pharmaceuticals, Inc..
| Peer-group chief executive median | $9,512,640 |
|---|---|
| Difference from that median | $-482,779 |
| Percentile within the disclosed peer group | 47th |
| Peers with a disclosed figure | 19 |
Medians and percentiles are computed across the peer group Arrowhead Pharmaceuticals, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Christopher Anzalone this page | President and Chief Executive Officer | $9,029,861 |
| Patrick O'Brien | Chief Operating Officer | $3,030,195 |
| James Hamilton | Chief Medical Officer | $2,966,213 |
| Kenneth Myszkowski | Former Chief Financial Officer | $2,660,161 |
| Tracie Oliver | Former Chief Commercial Officer | $43,193 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Arrowhead Pharmaceuticals, Inc. compensation brief.
Christopher Anzalone's compensation sits inside Arrowhead Pharmaceuticals, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.
The Arrowhead Pharmaceuticals, Inc. (ARWR) compensation brief